41 /100
MEDIUM RISK
Score updated Apr 13, 2026

SABS

SAB Biotherapeutics, Inc. — Stock Dilution Tracker

Track SABS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track SABS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $75M remaining capacity
🔔 Track SABS — Get forecast alerts →
💹 Market Data
Market Cap$263.53M
Shares Outstanding70.28M
Float34.88M
Cash$96.59M
Debt$5.95M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 29.8% shares (2025Q4 vs prior)
48 institutional holders · 36.37M shares
#1 Vivo Capital, LLC 11.42M shares
#2 RA CAPITAL MANAGEMENT, L.P. 4.40M shares
#3 Commodore Capital LP 4.40M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.50M
Days to Cover3.0
% of Float7.2%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Mar 25, 2026
424B5 ATM Mar 19, 2026
8-K 8K EVENT Mar 19, 2026
424B5 ATM Mar 17, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track SABS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SABS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required